GHIT Fund WEBINAR SERIES GHIT Fund WEBINAR SERIES

Advancing innovations through global partnerships for neglected diseases during and beyond the COVID-19 pandemic

COVID-19 has drawn unprecedented global attention to the value of innovation for life-threatening infectious diseases. The extraordinary speed of pandemic tool development over the past year demonstrates the innovation and scale that is possible when stakeholders are incentivized to collaborate meaningfully despite unprecedented challenges in their path. We at GHIT are committed to leveraging the power of this potential for R&D for neglected diseases.

Over the last two decades, product development partnerships (PDPs), international, non-for-profit organizations that develop health technologies—drugs, vaccines, diagnostics, vector controls, and devices—for neglected diseases, have played a pivotal role in the global health R&D ecosystem. PDPs have successfully registered and launched more than 85 new innovative life-saving products that have been in LMICs. Recognizing the unique capabilities and strengths of these entities, GHIT has catalyzed and invested in partnerships between PDPs and Japanese entities since 2013 dedicated to creating innovative products for malaria, tuberculosis, and neglected tropical diseases (NTDs) by harnessing untapped chemical/natural compounds, technologies and innovations in Japan. The results include multiple promising candidates in GHIT’s portfolio, several of which will emerge from the pipeline in the next couple of years.

To maintain momentum and foster dialogue about the R&D community’s role, challenges, and opportunities in the fight against neglected diseases during/post COVID-19 pandemic era, GHIT will convene a set of webinar series in FY2021. Webinars will feature leaders from PDPs and their Japanese partners and address the critical role of PDPs today and tomorrow, innovative R&D partnerships for neglected diseases, as well as responses to future global health threats by utilizing their expertise, portfolios, and partner networks.

November 2021

Coming soon

December 2021

Coming soon

January 2022

Coming soon

February 2022

Coming soon

March 2022

Coming soon

Past Webinars

2021.9.3

Session 1: Medicines for Malaria Venture (MMV) - Developing Life-Saving Antimalarials Through Global Partnerships

    Speaker
  • Dr. James Duffy, Director of Drug Discovery, Medicines for Malaria Venture
     (Presentation material)
  • Dr. Tomo Nozaki, Professor of Department of Biomedical Chemistry and Vice Dean of Graduate School of Medicine, The University of Tokyo
     (Presentation material)
  • Mr. Hiroki Kano, Senior Research Scientist, Discovery Technology Laboratories, Mitsubishi Tanabe Pharma Corp.
     (Presentation material)
  • Dr. Kei Katsuno, Senior Director, Investment Strategy, Business Development, GHIT Fund
     (Presentation material)